Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
levodopa dopamine d1 receptor small molecule NA drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Parkinson Disease
Postencephalitic[MeSHID:D010301]
Inspiration function[MeSHID:D001239]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.06 approved agonist
levodopa dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Parkinson Disease
Postencephalitic[MeSHID:D010301]
Inspiration function[MeSHID:D001239]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.12 approved agonist
levodopa dopamine d3 receptor small molecule NA drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Parkinson Disease
Postencephalitic[MeSHID:D010301]
Inspiration function[MeSHID:D001239]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.16 approved agonist
levodopa dopamine d4 receptor small molecule NA drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Parkinson Disease
Postencephalitic[MeSHID:D010301]
Inspiration function[MeSHID:D001239]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.11 approved agonist
levodopa dopamine d5 receptor small molecule NA drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Parkinson Disease
Postencephalitic[MeSHID:D010301]
Inspiration function[MeSHID:D001239]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.22 approved agonist
click here to return to the previous page